August 16, 2010 — Nebulized hypertonic 3% saline solution without adjunctive bronchodilators has a low rate of adverse events in infants younger than 2 years with bronchiolitis, according to the ...

Fixed long-acting combinations of both anticholinergic and beta-agonist bronchodilators, not previously available, have been developed. A new fixed combination of glycopyrronium and indacaterol has ...

Please provide your email address to receive an email when new articles are posted on . Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or ...

LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global bronchodilators market is expected to grow at a CAGR of close to 5% during the forecast period. This ...

A study of Korean patients with chronic obstructive pulmonary disease (COPD) found that a paradoxical response to short-acting bronchodilators may reduce lung function and quality of life. The study ...

Researchers find a 28 percent greater risk of heart attack and stroke in older patients taking commonly prescribed drugs for chronic obstructive pulmonary disease (COPD). Canadian scientists are ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators - long-lasting inhalers that relax the airways and make it easier to breathe - do little to help people ...

OBSTRUCTIVE pulmonary emphysema, as the term is used here, refers to a chronic progressive process manifested clinically by dyspnea, which most commonly makes its appearance in middle-aged or elderly ...

Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the airways and make it easier to breathe -- do little to help people who do not have chronic obstructive pulmonary ...

Researchers supported by the National Institutes of Health have found that dual bronchodilators – long-lasting inhalers that relax the airways and make it easier to breathe – do little to help people ...